CONJUPRI Tablet Ref.[49513] Active ingredients: Levamlodipine

Source: FDA, National Drug Code (US)  Revision Year: 2021 

Product description

The active ingredient levamlodipine maleate is the maleate salt of levamlodipine, the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker.

Levamlodipine maleate is chemically described as (S)3-ethyl-5-methyl-2-(2-aminoethoxymethyl)4(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate maleate, and its structural formula is:

Levamlodipine maleate is an off-white to light yellow crystalline powder with a molecular weight of 524.95. It is slightly soluble in water and sparingly soluble in ethanol. CONJUPRI (levamlodipine) tablets are formulated as white to off-white tablets containing 1.25, 2.5, and 5 mg of levamlodipine (equivalent to 1.6, 3.2, and 6.4 mg of levamlodipine maleate respectively), for oral administration. In addition to the active ingredient, levamlodipine maleate, each tablet contains the following inactive ingredients: betadex, colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, and pregelatinized starch.

Dosage Forms and Strengths

Tablet, 1.25 mg is white to off-white, oval, biconvex tablet, engraved with “OE” on one side and “B46” on the other side.

Tablet, 2.5 mg is white to off-white, capsule shaped, flat-faced tablet with functional score on each side, engraved with “OE” on one side and “B47” on the other side.

Tablet, 5 mg is white to off-white, soap shaped, flat-faced tablet with functional score on each side, engraved with “OE” on one side and “B48” on the other side.

How Supplied

1.25 mg Tablets

Levamlodipine – 1.25 mg tablets are supplied as white to off-white, oval, biconvex tablet, engraved with “OE” on one side and “B46” on the other side and supplied as follows:

NDC 69101-512-30 Bottle of 30 tablets with child-resistant closure
NDC 69101-512-90 Bottle of 90 tablets with child-resistant closure
NDC 69101-512-50 Bottle of 500 tablets

2.5 mg Tablets

Levamlodipine – 2.5 mg tablets are supplied as white to off-white, capsule shaped, flat-faced tablet with functional score on each side, engraved with “OE” on one side and “B47” on the other side and supplied as follows:

NDC 69101-525-30 Bottle of 30 tablets with child-resistant closure
NDC 69101-525-90 Bottle of 90 tablets with child-resistant closure
NDC 69101-525-50 Bottle of 500 tablets

5 mg Tablets

Levamlodipine – 5 mg tablets are supplied as white to off-white, soap shaped, flat-faced tablet with functional score on each side, engraved with “OE” on one side and “B48” on the other side and supplied as follows:

NDC 69101-550-30 Bottle of 30 tablets with child-resistant closure
NDC 69101-550-90 Bottle of 90 tablets with child-resistant closure
NDC 69101-550-50 Bottle of 500 tablets

Manufactured by: CSPC Ouyi Pharmaceutical Co., Ltd., Shijiazhuang, Hebei, China, 052160

Distributed by: Burke Therapeutics, LLC, Hot Springs, AR 71913, USA

Drugs

Drug Countries
CONJUPRI United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.